This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Prostate carcinoma : Vaccination as a new option for treatment - Abstract November 4, 2011
Clinical exercise interventions in prostate cancer patients-a systematic review of randomized controlled trials - Abstract November 4, 2011
Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localized prostate cancer: Initial experience of 160 men - Abstract November 3, 2011
Screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force - Abstract November 3, 2011
Prostate cancer health and cultural beliefs of black men: The Florida Prostate Cancer Disparity Project - Abstract November 3, 2011
Nodal counts during pelvic lymph node dissection for prostate cancer: An objective indicator of quality under the influence of very subjective factors - Abstract November 3, 2011
Pain in castration-resistant prostate cancer with bone metastases: A qualitative study - Abstract November 3, 2011
Oxidative stress and antioxidant status in prostate cancer patients: Relation to Gleason score, treatment and bone metastasis - Abstract November 3, 2011
Primary intermittent androgen deprivation as initial therapy for men with newly diagnosed prostate cancer - Abstract November 3, 2011
Editor's Commentary - Early continence in patients with localized prostate cancer. A comparison between open retropubic (RRPE) and endoscopic extraperitoneal radical prostatectomy (EERPE) November 3, 2011
Prostate cancer study shows radiation plus hormone therapy greatly improves survival for men with high-risk disease November 3, 2011
Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: An early sign of invasion and hormone-refractory cancer? - Abstract November 2, 2011
MicroRNAs associated with metastatic prostate cancer - Abstract November 2, 2011
Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: A nested case-control study in UK primary care - Abstract November 2, 2011
Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 Years of experience - Abstract November 2, 2011
Characterisation and manipulation of Docetaxel resistant prostate cancer cell lines - Abstract November 2, 2011
The metabolic syndrome and risk of prostate cancer in Italy - Abstract November 2, 2011
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses - Abstract November 2, 2011
Overall and worst Gleason scores are equally good predictors of prostate cancer progression - Abstract November 1, 2011
Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: A validation study - Abstract November 1, 2011
Page 1259 of 1351
  • Start
  • Prev
  • 1254
  • 1255
  • 1256
  • 1257
  • 1258
  • 1259
  • 1260
  • 1261
  • 1262
  • 1263
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free